跳至主要内容
临床试验/NCT00034801
NCT00034801已完成4 期

A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression

Eli Lilly and Company30 个研究点 分布在 1 个国家目标入组 378 人开始时间: 2001年9月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
378
试验地点
30

研究概览

简要总结

This is a research study comparing the safety and efficacy of two active study medications

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female subjects 18-60 years of age
  • •Female subjects of childbearing potential must be using a medically accepted means of contraception
  • •Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol
  • •Subjects must be considered reliable

排除标准

  • •Treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry
  • •Female subjects who are either pregnant or nursing
  • •Uncorrected hypothyroidism or hyperthyroidism
  • •Narrow-angle glaucoma

研究者

申办方类型
Industry

研究点 (30)

Loading locations...

相似试验